Top investigators applying proteomics to cancer research will be presenting their latest work, providing a unique opportunity to delegates to network with the most senior researchers in the field
Select Biosciences announces that the inaugural World Congress dedicated to OncoProteomics will be held on the 27-28 April 2006 in south San Francisco.
The top investigators applying proteomics to cancer research will be presenting their latest cutting edge work, providing a unique opportunity to delegates to network with the most senior researchers in the field.
Agenda sessions include:.
Alterations in the proteome in cancer.
Keynote speaker: Samir Hanash, director, Fred Hutchinson Cancer Research Center.
Molecular diagnostics for cancer.
Keynote speaker: Gordon Whiteley, director, Clinical Proteomics Reference Lab, NCI, Gaithersburg.
Protein biochips chaired by William Rich, CEO, Ciphergen.
Personalised therapies for cancer.
Keynote speaker: Jack Roth, professor and chairman, Anderson Cancer Center.
A full downloadable agenda (pdf) is available online.
Select Biosciences is focused on organising specialist biomedical meetings.
Experts from both academia and commerce present timely information from current research through to commercial implementation of new technologies.
